Todd Franklin Watanabe sold $272K of Arcutis Biotherapeutics (ARQT)

Executed Mar 3 2025, disclosed Mar 4 2025, 1 day later.

Value, as filed

$272K

20,880 sh × $13.03

Executed

Mar 3 2025

the trade date, as filed

Disclosed

Mar 4 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Todd Franklin Watanabe See Remarks profile →

Todd Franklin Watanabe (See Remarks) filed 5 Form 4 reports in the past 24 months (0 purchases, 5 sales), most often in Arcutis Biotherapeutics, Inc. (ARQT). The largest single filing was $272K of ARQT (20,880 sh × $13.03, as filed), executed Mar 3 2025.

The name

ARQT

Arcutis Biotherapeutics, Inc. ARQT · Healthcare · 65 filings in 24 months ticker →

Healthcare · Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Todd Franklin Watanabe in ARQT

ARQTSALE Arcutis Biotherapeutics, Inc. $174K
11,448 sh × $15.19
Exec May 2 2025
Filed May 5 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $245K
19,301 sh × $12.70
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $228K
15,000 sh × $15.17
Exec Dec 20 2024
Filed Dec 23 2024 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $120K
13,871 sh × $8.68
Exec Nov 4 2024
Filed Nov 5 2024 · 5:30 PM ET